Mr. Kaplan has 14 years of experience as a biotechnology analyst. His current research focus is therapeutic companies, cardiovascular, and drug delivery. Prior to joining Ladenburg Thalmann, he was a Partner and the Director of Healthcare Research with Punk, Ziegel & Company. Previously, he was a Senior Biotechnology Analyst at Evolution Capital and a Director of The Life Sciences Group at The Carson Group. Before joining The Carson Group and Evolution Capital, Mr. Kaplan had six years of experience as a Research Associate with the Albert Einstein College of Medicine/Montefiore Hospital Department of Cardiology. Mr. Kaplan received his bachelor’s degree in Biology from the University of Michigan and studied Cellular and Molecular Biology at Columbia University.